Glucocorticoid-induced gene-1 (Gig1) was identified in a yeast one-hybrid screen for factors that interact with the MyoD core enhancer. The Gig1 gene encodes a novel C2H2 zinc finger protein that shares a high degree of sequence similarity with two known DNA binding proteins in humans, Glut4 enhancer factor and papillomavirus binding factor (PBF). The mouse ortholog of PBF was also isolated in the screen. The DNA binding domain of Gig1, which contains TCF-E-tail CR1 and CR2 motifs shown to mediate promoter specificity of TCF-E-tail isoforms, was mapped to a C-terminal domain that is highly conserved in Glut4 enhancer factor and PBF. In mouse embryos, in situ hybridization revealed a restricted pattern of expression of Gig1 that overlaps with MyoD expression. A nuclear-localized lacZ knockin null allele of Gig1 was produced to study Gig1 expression with greater resolution and to assess Gig1 functions. X-gal staining of Gig1 nlacZ heterozygous embryos revealed Gig1 expression in myotomal myocytes, skeletal muscle precursors in the limb, and in nascent muscle fibers of the body wall, head and neck, and limbs through E14.5 (latest stage examined). Gig1 was also expressed in a subset of Scleraxispositive tendon precursors/rudiments of the limbs, but not in the earliest tendon precursors of the somite (syndetome) defined by Scleraxis expression. Additional regions of Gig1 expression included the apical ectodermal ridge, neural tube roof plate and floor plate, apparent motor neurons in the ventral neural tube, otic vesicles, notochord, and several other tissues representing all three germ layers. Gig1 expression was particularly well represented in epithelial tissues and in a number of cells/tissues of neural crest origin. Expression of both the endogenous MyoD gene and a reporter gene driven by MyoD regulatory elements was similar in wild-type and homozygous null Gig1 nlacZ embryos, and mutant mice were viable and fertile, indicating that the functions of Gig1 are redundant with other factors.
Introduction
The MyoD family of basic-helix-loop transcription factors regulates skeletal muscle determination and differentiation. MyoD and Myf-5 serve partially redundant functions in establishing the skeletal muscle lineage, and embryos carrying mutations in both factors are devoid of skeletal muscle (Rudnicki et al., 1993) . Considerable progress has been made in identifying the cis regulatory elements that control the expression of MyoD and Myf-5. In mammals, MyoD is regulated by two muscle-specific enhancers, the core enhancer positioned at À20 kb and the distal regulatory region (DRR) at À5 kb (Goldhamer et al., 1992 (Goldhamer et al., , 1995 Tapscott et al., 1992; Asakura et al., 1995) . These enhancers have largely complementary functions that together regulate the wild-type pattern of MyoD expression throughout embryogenesis. Transgenic and knockout data have shown that the core enhancer regulates the initial expression of MyoD in skeletal muscle precursor cells, suggesting that this element is a direct or an indirect target of upstream signaling events that control early myogenesis (Kablar et al., 1999; Chen et al., 2001; Chen and Goldhamer, 2004) . Very little is known, however, about the transcriptional pathways that directly regulate core enhancer activity.
We previously identified two adjacent linker-scanner mutations, LS4 and LS5, which define a 30 bp sequence (referred to here as required element 2; RE2) that is essential for core enhancer activity in all skeletal muscle lineages (Kucharczuk et al., 1999) . DNase I protection and electromobility shift assays have demonstrated that RE2 is bound by nuclear proteins in vitro, although their identity is not known (Goldhamer et al., 1995; unpublished observations) . Based on Transcription Element Search System analysis (TESS; Schug and Overton, 1997) , RE2 does not contain consensus binding sites for the effectors of signaling pathways known to be important in early myogenesis, including the Shh, Wnt, Notch, and BMP pathways (Munsterberg et al., 1995; Pourquie et al., 1996; Tajbakhsh et al., 1998; Borycki et al., 1999; Delfini et al., 2000) , suggesting that novel factors bind RE2 and regulate core enhancer activity.
Using a yeast one-hybrid screen for factors that interact with RE2, we report the isolation of two related genes, an uncharacterized gene referred to as Glucocorticoid-induced gene-1 (Gig1), and Pbf, the mouse ortholog of the transcriptional regulator, papillomavirus binding factor (PBF; Boeckle et al., 2002) . Gig1 was independently isolated in a screen for glucocorticoid-induced genes in thymocytes (Chapman et al., 1995) . Gig1 and Pbf proteins share a high degree of amino acid identity with the human transcription factor, Glut4 enhancer factor (Oshel et al., 2000) and, together, represent a new family of zinc finger DNA binding proteins (Tanaka et al., 2004) . Recently, Glut4 enhancer factor and PBF were independently isolated (referred to as HDBP1 and HDBP2, respectively) in a screen for transcriptional regulators of the human Huntington's disease gene (Tanaka et al., 2004) .
In situ hybridization and analysis of lacZ expression in heterozygous Gig1 nlacZ knockin embryos showed that Gig1 is expressed in MyoD-expressing muscle precursor cells and differentiating myocytes/fibers as well as in several other tissues, with prominent expression in subset of tendon precursors and definitive tendon rudiments. Additionally, Gig1 is expressed in the notochord, neural tube floor plate and apical ectodermal ridge, key signaling centers that control axial patterning and limb outgrowth. MyoD expression was not affected in Gig1 nlacZ homozygous null embryos, suggesting that functions of Gig1 in myogenesis are redundant, a possibility we are currently investigating.
Results

Isolation of RE2-interacting proteins
The RE2 sequence of the MyoD core enhancer, which corresponds to an essential region defined by linker-scanner mutants 4 and 5 (Kucharczuk et al., 1999) , was used as bait in a yeast one-hybrid screen in order to identify core enhancer-interacting factors. An E11.0 mouse embryo cDNA library was used, as the MyoD core enhancer is transcriptionally active at this stage (Goldhamer et al., 1995; Kablar et al., 1999; Kucharczuk et al., 1999) . Of 1.07 · 10 7 clones screened, 41 positive clones were isolated, 18 of which represented four highly related cDNA inserts. These four inserts conferred robust growth on selective media when re-transformed into the RE2 yeast reporter strain, but failed to confer growth to a yeast reporter strain based on the p53 binding site (data not shown). Preliminary analyses indicated that the remaining 23 clones were non-specific.
Sequence analysis showed that the four isolated cDNA inserts correspond to two related murine genes. Two of the inserts, isolated a total of 10 times, correspond to the predicted murine ortholog of human PBF (Pbf, Accession No. XM354825) (Boeckle et al., 2002) . The remaining two inserts, isolated a total of eight times, were derived from Gig1 (Chapman et al., 1995) . Gig1 cDNA was initially identified in WEHI 7.2 thymocytes in a screen for glucocorticoid-induced genes using mRNA differential display, and a full-length cDNA was cloned by screening a WEHI 7.2 cDNA library (GenBank Accession No. AF292939). The overall organization of the Gig1 protein is similar to that of PBF/pbf (42% identity/53% similarity with human PBF) and human Glut4 enhancer factor (44% identity/ 52% similarity) (Oshel et al., 2000) . Interestingly, mouse Glut4 enhancer factor was not isolated in the present screen, despite having a highly similar C-terminal DNA binding domain (see Section 3).
The Gig1 cDNA represents a 13.9 kb mRNA transcript that includes a 1.7 kb open-reading frame and an 11.8 kb 3 0 untranslated region. The Gig1 gene, which is located on chromosome 3 A1, is predicted to have nine exons spanning 182.1 kb (see Fig. 4 ), based on sequence comparison to the cDNA. An additional mRNA species may be generated by alternative splicing, based on a recent cDNA entry in the EMBL database (BC083106). The mature transcript encodes a 566 amino acid protein with the following motifs/features ( Fig. 1 ; also see Tanaka et al., 2004) : a centrally located C2H2 zinc finger, a putative nuclear localization signal (PIPRKRK), a putative nuclear export signal (MDKVTAAMVL) that is conserved at key hydrophobic residues with a nuclear export signal in PBF (MDEM-MAAMVL), a serine-rich region (SRR), two proline-rich regions (PRR), and a highly conserved C-terminal basic domain that has been shown to mediate DNA binding of Glut4 enhancer factor and PBF (Boeckle et al., 2002; Tanaka et al., 2004) . The DNA binding domain includes TCF-E tail CR1 and CR2 motifs (KKCRARFGX+-X 4 -WC-X 2 -CRRKKKC-X-RXX), which influence promoter specificity of TCF-E isoforms (Atcha et al., 2003) .
Analysis of genomic and EST databases revealed predicted genes related to Gig1 in a variety of other vertebrate species, including rat, chicken, frog, zebrafish, and pufferfish (data not shown). A single predicted gene related to Gig1 is also present in Drosophila (CG11676; Accession No. NM141707).
Functional identification of the Gig1 DNA binding domain
Glut4 enhancer factor and PBF have been shown to bind to the core sequence, CCGG (Oshel et al., 2000; Boeckle et al., 2002; Tanaka et al., 2004) , whereas RE2 of the MyoD core enhancer contains the related sequence CCTG. In electromobility shift assays (EMSA), bacterially-purified GST-Gig1 fusion protein bound to the canonical CCGG sequence of the human papillomavirus P2 element (Boeckle et al., 2002) , but not to the RE2 element (data not shown). This may reflect a lower affinity for the CCTG site, or the need for additional cellular co-factors for DNA binding. The smallest cDNA isolated in the one-hybrid screen included the last 285 bp of Gig1 coding sequence (data not shown), suggesting that this region contains an RE2 recognition motif. As a functional test for Gig1 binding to RE2, and to map the RE2 recognition domain, a series of VP16 activation domain (AD) fusions were tested in 10T1/2 cells for their ability to activate a reporter system based on RE2 ( Fig. 2A and B) . All VP16 AD-Gig1 fusion proteins were expressed and nuclear-localized (Fig. 2D) . The largest fragment examined, residues 394-566 of Gig1, exhibited sequence-specific activation of the RE2 reporter (4 · RE2 UASR) when fused to VP16 (Fig. 2C) . Three smaller C-terminal fragments were tested to narrow the location of the putative DNA binding domain (Fig. 2B) . No activation was observed with either pVP16 394-470 or pVP16 514-566, while pVP16 471-566 retained activity in this assay (Fig. 2C) . Also, no significant activity was observed when any of the VP16 activation domain fusions were tested against a control reporter that lacks RE2 sites (UASR) or has linker sequences (4 · LSM UASR) in place of RE2 (Fig. 2C) , mutations that destroy enhancer activity in transgenic mice (Kucharczuk et al., 1999) . Thus, the smallest identified RE2 recognition motif spans the last 96 residues of Gig1, which contains conserved region 3 (CR3; Tanaka et al., 2004) and its associated TCF-E CR1/CR2 motifs (Atcha et al., 2003) . Although the CR3 region of Glut4 enhancer factor and PBF is sufficient to mediate sequence-specific DNA binding in EMSAs (Tanaka et al., 2004) , the present data demonstrates that pVP16 514-566, which includes CR3, is not sufficient to mediate RE2-specific activation (Fig. 2C) . To determine whether the TCF-E CR1/CR2 motif was necessary for sequence-specific recognition, two mutations were introduced into Gig1 471-566 ( Fig. 2B ; pVP16 TECR1mut and pVP16 TECR2mut) that were shown to inactivate TCF-E CR1/CR2 (Atcha et al., 2003) . Neither of the Gig1 mutants was able to activate a RE2-based reporter (Fig. 2C) , demonstrating that an intact TCF-E CR1/CR2 motif is necessary for RE2 sequence recognition. Fig. 1 . Gig1 protein features. The predicted amino acid sequence of Gig1 is shown with the following protein features indicated: C2H2 zinc finger (yellow), putative NLS (dots), putative NES (asterisks), serine-rich region (green), two proline-rich regions (blue), TCF-E CR1 and CR2 motifs (Atcha et al., 2003; gray) and three previously defined conserved regions, CR1, CR2, and CR3 (Tanaka et al., 2004) shared between Gig1, Pbf, and GEF (orange). The Cterminal DNA binding domain and the TCF-E CR1 and CR2 motifs are located within CR3.
Overview of Gig1 expression
Gig1 was expressed at all stages of embryogenesis examined, from E9.5 through E14.5, as revealed by RT-PCR (data not shown) and whole mount in situ hybridization (Fig. 3) . Prominent staining was observed in somites, particularly in epaxial domains (Fig. 3A-C) , in limb bud mesenchyme ( Fig. 3B and C) and in the otic vesicle (Fig. 3A-C) . Because of a poor signal-to-noise ratio with Gig1 in situ probes in some tissues ( Fig. 3 ; data not shown), and relatively low resolution of whole mount in situ methods, positive identification of a number of Gig1-expressing cell/ tissue types was not possible. To characterize Gig1 expression with greater resolution and reduced background, we produced an nlacZ knockin allele of Gig1 (Gig1 nlacZ ) in which the nlacZ gene encoding nuclear-localized b-gal followed by 3-tandem SV40 polyadenylation sequences replaced most of exon 1 coding sequence, creating a fusion with the first five amino acids of Gig1 (Fig. 4A and B) . Of 24 ES cell clones screened, nine clones were correctly Fig. 2 . The Gig1 DNA binding domain maps to a conserved C-terminal region that includes TCF-E CR1 and CR2 motifs. (A) Schematics of the luciferase reporters. UASR contains three tandem copies of the Gal4 UAS cloned upstream of a minimal goosecoid promoter (GSC). 4 · RE2 UASR and 4 · LSM UASR have four tandem copies of wild-type and mutant RE2, respectively, cloned upstream of UAS sequences. (B) Schematics of the VP16 AD-Gig1 fusions used to map the RE2 recognition motif. The relative locations of the C2H2 zinc finger (yellow), putative NLS (closed arrowhead), putative NES (open arrowhead), TCF-E CR1 and CR2 motifs (gray), and the three conserved regions, CR1, CR2, and CR3 (orange), are indicated. The mutant TCF-E CR1/CR2 motif is shown in black. The TCF-E CR1 motif (pVP16 TECR1mut) was changed from KKCRKVYGME to VALALVYGME. The TCF-E CR2 motif (pVP16 TECR2mut) was changed from WCTACRWKKACQRFI to WCTAVALALACQRFI. (C) The average of three independent luciferase assays done in duplicate in 10T1/2 cells is shown. Fold activation corresponds to the ratio of the normalized activity of a test plasmid to the normalized activity of the UASR reporter challenged with pVP16. (D) An anti-VP16 antibody was used for immunofluorescence detection of VP16 ADGig1 fusions in transfected 10T1/2 cells. All fusions were expressed and nuclear-localized (red; top and bottom panels). Cells stained only for DAPI in the bottom panel serve as untransfected controls.
targeted; three clones were chosen for chimera formation, and two exhibited germ-line transmission. Gig1 transcripts were not detected in Gig1 nlacZ/nlacZ embryos by RT-PCR (Fig. 4C ) using primers anchored in exon 2, or in exons 7 and 9, indicating the absence of read-through transcription past the nlacZ cassette. As all mouse Gig1 EST database entries (ENSEMBL) include exons 7-9, it is unlikely that 5 0 -truncated Gig1 transcripts are produced by internal promoter utilization. Collectively, these data indicate that Gig1 nlacZ is a true null allele and that nlacZ expression provides an accurate read-out of Gig1 transcription and translation.
X-gal staining of Gig1 nlacZ/+ embryos revealed Gig1 expression in derivatives of all three germ layers ( Fig. 5 and Table 1) , with prominent representation in mesodermal derivatives, including developing skeletal muscles and tendons (described in detail below), and in the notochord in the posterior region of the embryo (Fig. 5B , C, and I). Ectodermal derivatives include key signaling centers in the embryo, such as the neural tube roof plate and floor plate (Fig. 5E ), and the apical ectodermal ridge (AER) of the limb bud ( Fig. 5B and C). Other ectodermal derivatives exhibiting staining include the otic vesicle epithelium (Fig. 5A -C and H), apparent motor neurons in the ventral Fig. 3 . In situ hybridization detection of Gig1 mRNA. At mid-gestational stages, Gig1 is prominently expressed in somites (arrowheads in A-C), particularly in epaxial domains. Expression is also observed in limb bud mesenchyme (red arrows, B and C) and the AER (also see Fig. 6 ), in the otic vesicle (asterisk, A-C) and in the nephrogenic mesoderm in the posterior of the embryo (yellow arrowhead, A). Other areas of expression were identified by lacZ expression in Gig1 lacZ/+ knockin embryos. neural tube (Fig. 5E ), and skin epithelium, which is visible in the tail by E10.5 (Fig. 5I) , and becomes prominent throughout the embryo by E14.5 (see Fig. 8D -H). Although marker studies are required for definitive identification, staining in the dorsal neural tube and mesenchymal cells subjacent to the ectoderm in the dorsal embryo (not shown), in sympathetic chain ganglia (Fig. 5G ), in the walls of vascular elements in the trunk ( Fig. 5F and G), and in mesenchymal cells of the developing heart (not shown), is consistent with Gig1 expression in neural crest and a number of neural crest derivatives. Among endodermal derivatives, the thyroid rudiment ( Fig. 5F ) represents the most prominent Gig1-expressing tissue at the stages examined. Although a comprehensive study of Gig1 expression in the adult has not been undertaken, we have observed prominent expression in several regions of the brain, including the cerebral cortex, dentate gyrus, and olfactory bulbs (data not shown). Interestingly, despite robust expression in developing musculature of the embryo, we have not detected X-gal staining in mature or regenerating skeletal muscle in adult Gig1 nlacZ/+ mice (unpublished observations).
Gig1 expression in developing skeletal muscles and tendons
At E9.5-9.75 ( Fig. 5A ), X-gal staining was observed in the first 8-12 occipito-cervical somites, and followed an anterior to posterior sequence of activation ( Fig. 5B and C), paralleling the gradient of somite formation and maturation. Expression of Gig1 in somite myotomes was confirmed by co-expression of a MyoDGFP transgene (À24GFP) that faithfully recapitulates MyoD expression and marks all skeletal muscle regions ( Fig. 6 ; data not shown). In this transgene (Fig. 6A ), GFP expression is directed by 24 kb of MyoD 5 0 flanking sequences, which include the two known MyoD enhancers, the core enhancer (Goldhamer et al., 1992 (Goldhamer et al., , 1995 and distal regulatory region (Asakura et al., 1995) . lacZ expression directed by identical sequences has been described in detail (Chen et al., 2001 ). At E10.5, X-gal staining was most prominent in the central myotomes of interlimb somites and was absent from the lateral hypaxial domain (Figs. 5B and 6C-E). At E11.5, staining remained most intense in the central myotomes, although weak expression was now observed in a portion Gig1 nlacZ/nlacZ embryo processed for whole mount in situ hybridization for lacZ mRNA. (A) At E9.5, the anterior somites (black arrowheads), branchial arches (black arrows), otic vesicle (asterisk), and the flank mesenchyme (white arrow) just posterior to the emerging forelimb buds are X-gal stained. In the posterior of the embryo, the nephrogenic mesoderm is strongly positive (yellow arrowhead), and the notochord is weakly stained (not shown). (B) In addition to expression domains observed at E9.5 (labeling is the same as in (A)), X-gal staining of E10.5 embryos revealed lacZ expression in the centro-medial limb bud mesenchyme (red arrow), in the AER of the forelimb (red arrowhead) and hindlimb buds, and in the posterior notochord (white arrowhead). X-gal staining of somites extends to the hindlimb bud level and is most prominent in the epaxial domain. of the hypaxial myotome (Figs. 5C and 6F-H). In situ hybridization for Gig1 (Fig. 3) and lacZ (Fig. 5D ) mRNA also showed predominantly epaxial expression. At later stages, intercostal muscles and epaxial deep back muscles were X-gal-stained (not shown).
In the limbs, expression of lacZ was first detected at E10-10.5 in mesenchymal cells located centro-medially that include portions of the pre-muscle masses ( Fig. 5B ; data not shown). Muscle forming regions located more proximally in the limb bud did not show X-gal staining (Fig. 5B) . By E11.5, lacZ expression had extended to more proximal regions of the limb Figs. 5C, D and 7A-C and was observed in definitive muscle beds at E14.5 (Fig. 8I-H) , although muscle-to-muscle variation in X-gal staining was observed, and not all muscle groups exhibited X-gal staining (Fig. 7A-C,G-I) . In developing muscles, X-gal staining was observed in a broader domain than MyoD expression, and included both GFP-positive and GFP-negative cells within the muscle beds ( Fig. 7D-I , data not shown). In this regard, the pattern of X-gal staining in the early limb bud was similar to the pattern of expression of Scleraxis, which encodes a bHLH transcription factor (Cserjesi et al., 1995) and is a marker for tendon and ligament precursors (Schweitzer et al., 2001; Brent et al., 2003; Fig. 8A-C) . That the muscle-associated Gig1 expression at E10.5 and E11.5 represents expression in tendon precursors is suggested by the robust lacZ expression in definitive tendon rudiments at E14.5 (Fig. 8D-G) . Interestingly, X-gal staining was observed in apparent tendon precursors and tendon rudiments in the distal limb, whereas proximal tendon elements were weakly stained or unstained (Fig. 8E-H ). This contrasts with Scleraxis expression in apparently all tendon precursor populations and tendon rudiments along the proximo-distal axis of the limb ( Fig. 8C ; Schweitzer et al., 2001 ). In addition to Gig1 expression in muscle and tendon lineages in the limb, Gig1 expression was also observed in the skin ectoderm, with a ''cap'' of strongly stained ectoderm covering the tips of the digits, and was particularly intense in the developing footpad mesenchyme and overlying ectoderm (Fig. 8D, F, and G) . Although absent from pre-cartilage mesenchyme and definitive condensing cartilage of the limb skeleton, lacZ expression was localized to sites of joint formation in E14.5 embryos ( Fig. 8D and E) .
Scleraxis also is expressed in early tendon precursors of the axial skeleton, marking a newly defined somite sub-compartment, the syndetome (Brent et al., 2003) . In contrast, somitic expression of Gig1 was restricted to the myotomes (Figs. 5A-D and 6) , and X-gal staining was not detected in axial tendons or their precursors, as identified by Scleraxis expression, in Gig1 nlacZ/+ embryos (Fig. 8A) .
MyoD expression in Gig1
nlacZ/nlacZ embryos Gig1 nlacZ/nlacZ mice are viable and fertile and preliminary analyses did not detect obvious developmental defects. Targeted deletion of the MyoD core enhancer results in delayed MyoD expression in branchial arch and limb myogenic populations (Chen and Goldhamer, 2004) . To test whether Gig1 is essential for core enhancer activity, we performed in situ hybridization for MyoD on Gig1 nlacZ/nlacZ embryos. Comparison of heterozygous and homozygous null embryos revealed no differences in the pattern or intensity of in situ hybridization signals (data not shown). Expression of À24GFP also was not affected in Gig1 nlacZ/nlacZ embryos. This lack of phenotype could reflect functional compensation between Gig1 and Pbf, a possibility we are currently exploring.
Discussion
In this study, two highly related cDNAs, Gig1 and Pbf, were isolated in a yeast one-hybrid screen for factors that interact with a required element (referred to here as RE2) of the MyoD core enhancer (Goldhamer et al., 1995; The X-gal signal associated with the muscle beds includes non-muscle mesenchyme (white arrowheads). Not all developing muscles in the proximal limb bud and body wall are X-gal-positive (e.g., red arrowhead). (A, D, and G) bright-field images; (B, E, and H) fluorescence images; (C, F, and I) merge of X-gal and GFP signals. In (F and I) the GFP signal was colorized red to better show GFP and X-gal co-localization. Sections were counterstained with DAPI. Kucharczuk et al., 1999) . Pbf is the mouse ortholog of the human gene PBF, which encodes a DNA binding factor that regulates papillomavirus gene expression (Boeckle et al., 2002) , whereas Gig1 is a heretofore uncharacterized gene that is induced in thymocytes following glucocorticoid treatment (Chapman et al., 1995) . Gig1 and Pbf proteins share a high degree of sequence similarity with the human transcription factor, Glut4 enhancer factor, which has been implicated in the insulin-dependent regulation of the GLUT4 gene (Oshel et al., 2000; Knight et al., 2003) . Interestingly, Glut4 enhancer factor and PBF also interact with an essential neuronal specific element located in the promoter of the Huntington's disease gene (Tanaka et al., 2004) . Collectively, Gig1, PBF/Pbf, and Glut4 enhancer factor represent a new family of DNA binding proteins that are probably components of transcriptional pathways that regulate a number of developmental and physiologic processes. In the trunk at E11.5, somitic X-gal (blue; white arrowheads) and Scleraxis (purple-brown; red arrowheads) signals are nonoverlapping. Scleraxis, but not Gig1, is expressed in rib pre-cartilage (asterisks). In the limb, Scleraxis (yellow arrowhead) is expressed more proximally than lacZ (see panels B and C). (B and C) In the hindlimb bud at E12.5, X-gal staining (B) is restricted to the centro-medial portion of the limb bud (bracket), overlapping with Scleraxis expression (C), but is absent from more lateral, distal, and proximal areas of Scleraxis expression (red arrowheads). The bracket in (C) corresponds to the limits of Gig1 expression shown in (B). (D) Whole mount X-gal stain of the forelimb at E14.5. Ventral view is shown. X-gal staining is robust in the distal tendon rudiments (black arrowheads), developing footpads (red arrowheads), digital joints (orange arrowheads) and in the skin capping each of the digits (1-5). Dotted lines (E-H) correspond to the approximate position of the transverse paraffin sections shown in panels (E-H). (E) Section through digits 2-4, showing intense X-gal staining in developing ventral tendons (arrowheads). A dorsal tendon (arrowhead) is also stained. The inset is a horizontal section of digit 3, showing X-gal staining of the joints (orange arrowheads). (F) Section through the proximal digits showing staining of ventral and dorsal tendons (e.g., arrowheads), developing musculature (e.g., arrows), and mesenchyme and overlying ectoderm of the developing footpads (red arrowheads). (G) Section through the distal-radius/ulna. Some (e.g., black arrowhead) but not all (white arrowheads) tendon rudiments are stained at this level. An example of a tendon rudiment that is stained at this level, but not at more proximal levels (H), is marked with an asterisk. (H) In the proximal forelimb, tendon rudiments are not stained (white arrowheads). Developing muscles (e.g., black arrows) are stained. R, radius; U, ulna. In (E-H), dorsal is oriented toward the top of each panel.
The region of Gig1 responsible for DNA binding resides in the C-terminal region spanning residues 473-566, as these residues comprise the smallest Gig1 cDNA clone isolated in the one-hybrid screen, and sequence-specific DNA binding domains have been identified within the corresponding C-terminal portions of Glut4 enhancer factor and PBF (Tanaka et al., 2004) . Further, Gig1 471-566 was sufficient to mediate RE2-specific reporter activation when fused to the VP16 activation domain. Although Gig1, like Glut4 enhancer factor (Oshel et al., 2000; Tanaka et al., 2004) and PBF (Boeckle et al., 2002; Tanaka et al., 2004 ) binds a core CCGG motif (data not shown), we have been unable to demonstrate in vitro binding of Gig1 to RE2, which contains the related sequence, CCTG. This may reflect the need for co-factors for high affinity binding of Gig1 to RE2, although we cannot rule out the formal possibility that Gig1 activates transcription indirectly, by heterodimerization with an unknown RE2 binding protein expressed in yeast and mammalian cells. In this regard, the single C 2 H 2 zinc finger, which is not required for DNA binding, appears to function as a protein-protein interaction domain (unpublished observations). Additionally, the TCF-E CR1 and CR2 motifs, which are necessary but not sufficient for activation of the RE2 reporter, may influence DNA target specificity, either by mediating direct DNA binding or as protein interaction domains, as shown for specific TCF-E tail isoforms (Atcha et al., 2003; Hecht and Stemmler, 2003) .
Gig1 expression was investigated by whole mount in situ hybridization for endogenous Gig1 mRNA, and X-gal staining of Gig1 nlacZ/+ embryos. X-gal staining provided greater resolution and signal-to-noise ratio compared to Gig1 in situ hybridization, and was the primary method used to evaluate Gig1 expression. For areas of prominent Gig1 expression in which comparisons can be made, such as somites, otic vesicles, limb bud mesenchyme, and nephrogenic mesoderm, in situ hybridization and X-gal staining showed good agreement, although staining patterns were not identical (compare Figs. 3 and 5) . The pattern of expression revealed by X-gal staining is expected to reflect Gig1 transcriptional and translational activity, as the vector design did not alter the Gig1 initiation codon or 5 0 untranslated sequences. Therefore, region-specific translational control could contribute to differences observed, although the close agreement of X-gal staining and in situ hybridization for lacZ mRNA (Fig. 5C and D) suggests that this is not a major factor. Alternatively, differential stabilities of Gig1 and lacZ mRNAs could account for observed differences.
Gig1 is expressed in various tissues/embryonic regions representing all three germ layers. In addition to expression in developing skeletal muscle and tendons (see below), several features of Gig1 expression are of particular note. First, Gig1 expression was observed in key embryonic signaling centers, including the AER of the limb buds, the neural tube floor plate and roof plate, and the notochord in posterior regions of the embryo. Second, Gig1 is expressed in a number of epithelial cell types with representatives from all three germ layers, including restricted expression in neural ectoderm, surface ectoderm, otic vesicle epithelium, endolymphatic duct, pharyngeal epithelium, nephrogenic mesoderm, and others (Table 1) . Interestingly, the epithelial dermomyotome, from which the Gig1-positive myotome is derived, did not express Gig1. Third, neural crest derivatives are prominently represented among Gig1-expressing cell types (Table 1) . Given the diversity of cell types that express Gig1, it is premature to speculate as to its functional significance in these disparate cells/tissues. We note, however, that preliminary data indicate that Gig1 has potent transcriptional repression activity and interacts with transcriptional co-repressors in yeast twohybrid assays (unpublished observations).
Gig1 expression marks skeletal muscle precursors and differentiating skeletal muscles as shown by the temporal and spatial overlap with MyoD expression. However, distinct differences in Gig1 and MyoD expression were noted. For example, while both genes were expressed in the myotomes at E9.5-E9.75, Gig1 was expressed in the anterior, older myotomes, whereas MyoD is first expressed in interlimb somites (Tajbakhsh et al., 1997; Chen et al., 2001) . Further, at E10.5 and E11.5, Gig1 expression is most pronounced in the epaxial myotomal domain, whereas MyoD is expressed throughout the myotomes, and exhibits prominent expression in the hypaxial domain of interlimb somites (present study; Goldhamer et al., 1995; Tajbakhsh et al., 1997; Chen et al., 2001) . Finally, Gig1 expression in the limbs shows pronounced regional variation, with expression most prominent in muscle precursor populations and early differentiating muscle masses located in the distal myogenic populations of the limb bud; Gig1 expression was low or absent in several of the most proximal muscles of the limbs and associated girdles.
Gig1 expression in the limb mesenchyme showed significant overlap with Scleraxis expression, which marks tendon and ligament precursors in the chick and mouse (Schweitzer et al., 2001; Brent et al., 2003) . Both genes are expressed in the proximo-medial and sub-ectodermal limb mesenchyme at early limb bud stages, show extensive overlap with MyoD expression but are expressed in a broader domain associated with the developing muscle masses, and are expressed in definitive tendon rudiments at later stages. Unlike Scleraxis, however, Gig1 expression was most prominent in central and distal limb mesenchyme and definitive tendon rudiments and, in this regard, more closely resembles the expression of the distal tendon markers EphA4 and follistatin, which specifically mark autopod tendons in the chick (Patel et al., 1996; D'Souza and Patel, 1999) . Further, Scleraxis appears to be an earlier tendon marker than Gig1, based on the presence of Scleraxis mRNA in tendon precursors associated with condensing digit cartilage at E12.5, prior to the onset of Gig1 expression in these distal tendon precursors (Fig. 8) . Also, Gig1 expression was not detected in the syndetome, the newly defined somite sub-compartment comprised of tendon precursors that are marked by Scleraxis expression and which form the tendons associated with the axial skeleton (Brent et al., 2003) . Collectively, these data suggest that Gig1 expression marks a sub-population of tendon precursors restricted to the limb, particularly the distal limb. It will be important to determine whether these regional differences in Gig1 expression in limb muscle and tendon precursors is a response to positional signals, or reflects intrinsic differences in these precursor populations (see Schafer and Braun, 1999) .
Targeted deletion of the entire 258 bp core enhancer results in a delay in MyoD expression in branchial arches and limb buds (Chen and Goldhamer, 2004 ), yet the absence of Gig1, which binds a required region of the core enhancer, did not phenocopy this expression defect. Similarly, expression of the À24GFP transgene, which includes the core enhancer, was unaffected in Gig1 nlacZ/nlacZ embryos (not shown). That Gig1 nlacZ is a true null allele is indicated by RT-PCR analysis, which did not detect Gig1 transcripts in Gig1 nlacZ/nlacZ embryos using either exon 2 primers, or primers anchored in exons 7 and 9, which span sequences that encode the highly conserved C-terminal region of the protein. One possibility is that Gig1 regulates subtle aspects of MyoD expression that were not detectable by the present expression analysis. Alternatively, functions of Gig1 may overlap with those of other factors, or such factors may functionally compensate when Gig1 is absent. Two obvious candidates are Pbf and Glut4 enhancer factor, given their high degree of structural relatedness with Gig1, particularly in the C-terminal DNA binding domain. Interestingly, while a probable mouse ortholog of human Glut4 enhancer factor gene has been identified in EST and genomic databases (not shown), the mouse gene does not appear to encode a full-length functional protein due to the presence of numerous termination codons that interrupt the openreading frame (unpublished observations). The results of the yeast one-hybrid screen are consistent with this notion, as Glut4 enhancer factor was not represented among the 18 specific cDNA clones that were isolated, all of which represented either Gig1 or Pbf. Gene targeted will address overlapping functions of Gig1 and Pbf.
Experimental procedures
Yeast one-hybrid screen
The MATCHMAKER one-hybrid screen system (BD Biosciences Clontech) was used to identify proteins that bind to RE2. RE2 consists of a 30 bp sequence defined by linker-scanner mutagenesis (LS4 and LS5; Kucharczuk et al., 1999) with an additional 5 bp of upstream and downstream flanking sequence. Eight tandem copies of the 40 bp element (5 0 -TCTGAGAGGGT AACTTTATCCTGCTTCTTTCAGCCAAGTA-3 0 ), each separated by a 6 bp linker sequence (GGATCT; used for concatemerization) were cloned into the EcoRI and XbaI sites of pHis-1. Using homologous recombination, 8 · RE2 pHis-1 was integrated into the genome of YM4271 to generate a stable reporter strain. His À media supplemented with 7.5 mM 3-amino-1,2,4-triazole (Sigma) was sufficient to suppress background growth of the 8 · RE2 pHis-1 reporter strain. Using a LiCl/PEG transformation protocol (Gietz and Woods, 1998) , the 8 · RE2 pHis-1 reporter strain was used to screen an 11.0 dpc mouse embryo cDNA library (BD Biosciences Clontech) according to manufacturer's recommendations. Plasmid DNA was recovered from transformants (YEASTMAKER yeast plasmid isolation kit, BD Biosciences Clontech) that generated colonies greater than 2 mm in diameter on His À /Leu À media supplemented with 7.5 mM 3-amino-1,2,4-triazole after 6 days of incubation at 30°C. Isolated cDNAs that supported growth when re-transformed into the 8 · RE2 pHis-1 reporter strain were selected for further study.
Sequence analysis
cDNA inserts were sequenced at the University of Pennsylvania Department of Genetics DNA Sequencing Facility. Web-based BLAST searches were performed against either the Genbank or Ensembl database. PSORTII (http://psort.ims.u-tokyo.ac.jp/) was used to locate potential nuclear localization signals. TESS (http://www.cbil.upenn.edu/tess/) was used to analyze RE2 for potential transcription factor binding sites.
4.3. Cloning of full-length Gig-1 WEHI 7.2 cells were treated with dexamethasone for 8 h, after which total RNA was prepared by a single-step guanidine thiocyanate lysis method and was enriched for polyadenylated RNA using an oligo(dT) cellulose column (Gibco-BRL). Universal RiboClone cDNA synthesis system (Promega) and oligo(dT) or Gig1 specific internal 3 0 primers were used to prepare cDNA. Size-fractionated and adaptor-ligated cDNA fragments were cloned into the Lambda Zap II vector (Stratagene) and packaged using Gigapack III Gold packaging extracts (Stratagene). cDNA library screening and plasmid excision were performed according to the manufacturer's suggestions. Identified cDNA inserts were then sequenced and assembled.
Generation of expression constructs
Full-length Gig1 coding sequence was amplified using the GC-RICH PCR system (Roche) with the following PCR primer pair: 5 0 -gtgaattccaggcatgcagg c-3 0 (forward) and 5 0 -cgtgtcgacgctcagtcaatgaa-3 0 (reverse). The PCR product was cloned into the EcoRI and SalI sites of pBluescript KS+, and then subcloned into pVP16 (BD Biosciences Clontech). Deletions were made using either available restriction enzyme sites or standard PCR methods. Point mutations were introduced into pVP16 471-566 by PCRbased site-directed mutagenesis with PfuTurbo (Stratagene) and the following PCR primer pairs: 5 0 -GGAGAAGGCGTAGCGCTCGCACTAGTT TATGGGATGGAAAACAGG-3 0 (TECR1mut, forward); 5 0 -CCTGTTT TCCATCCCATAAACTAGTGCGAGCGCTACGCCTTCTCC-3 0 (TECR 1mut, reverse); 5 0 -GGTGCACCGCCGTAGCCCTGGCACTAGCCTGC CAGCGGTTCATTG-3 0 (TECR2mut, forward); 5 0 -CAATGAACCGCTG GCAGGCTAGTGCCAGGGCTACGGCGGTGCACC-3 0 (TECR2mut, reverse). Point mutations and correct reading frames were confirmed by DNA sequencing.
The wild-type reporter (4 · RE2 UASR) was produced by inserting four tandem copies of RE2 upstream of the Goosecoid minimal promoter (À104 Gsc; Watabe et al., 1995) in the luciferase reporter plasmid, pGL3 (Promega). The mutant reporter (4 · LSM UASR) was constructed by replacing four copies of RE2 with four copies of an unrelated, transcriptionally inert, sequence (Kucharczuk et al., 1999) . Three tandem GAL4 Upstream Activating Sequence elements (UAS, 5 0 -CGGAGGACAG-TACTCCG-3 0 ) were inserted between wild-type or mutant RE2 elements and the minimal promoter, to allow for the use of GAL4-VP16 as a positive control, which consistently generated >100-fold activation with each of the reporters tested (data not shown).
Luciferase reporter assays
10T1/2 cells were plated at a density of 1.7 · 10 4 cells/well in 24 well plates 20 h prior to transfection. Using FuGENE 6 (Roche), luciferase reporter plasmids (180 ng) were co-transfected with an expression plasmid (20 ng) and a SV40pRL internal control (2 ng). Competition between experimental and control plasmids was minimal using these quantities of DNA. Cells were harvested 48 h after the transfection and reporter activity was measured with a Turner luminometer using the Dual Luciferase Reporter Assay System (Promega). Fold activation was calculated relative to the activity of the UASR control reporter co-transfected with an empty expression vector (pVP16). Each experimental condition was performed in duplicate and experiments were repeated three times. Calculations and standard statistical analysis were performed using Microsoft Excel X. Error bars represent two standard errors.
Transgenic and knockout constructs
The MyoDGFP (À24GFP) transgene was constructed by excising 24 kb of human MyoD 5 0 flanking sequence from À24lacZ (Chen et al., 2001 ) by digestion with SalI and AscI (AscI linkers were added to the unique XhoI site at the 3 0 end of human genomic sequences) and inserting into SalI and AscI (produced by linker addition to the unique SmaI site) sites in the polylinker of pEGFP-1 (Clontech). Prior to subcloning, the NotI site just 3 0 of EGFP was destroyed by blunt-ending with Klenow, and a new NotI site was introduced by linker addition to the AflII site, which lies 3 0 of SV40 poly sequences. The plasmid was double-banded in cesium chloride equilibrium gradients, excised from vector sequences with Not1 (a 5 0 NotI site lies just 3 0 of the SalI site used for subcloning), and purified as previously described (Goldhamer et al., 1995) .
The Gig1 targeting vector was designed to replace exon 1 sequences encoding amino acids 6-150 and the first 169 bp of intron 1, with NLS-lacZ (nlacZ) followed by three tandem SV40 termination/polyadenylation sequences (3 pA) and a floxed PGKNeo cassette. pCITE-pA was generated by inserting a SV40 polyadenylation sequence (blunted BamHI-MluI fragment of pEGFP-C3 (Clontech)) into the blunted BamHI site of pCITE-2a (Novagen). The same blunted SV40 polyadenylation sequence was sequentially introduced into the blunted BamHI site of pCITE-pA to generate pCITE-2 pA. An nlacZ cassette with three SV40 polyadenylation sequences was generated by inserting the two-tandem SV40 polyadenylation sequence from pCITE-2pA into the NotI site of pPD46.21 (Fire et al., 1990) , to produce pPDnLacZ3pA. pPD5 0 Gig1nLacZ3pA was constructed by inserting the Gig1 5 0 UTR (366 bp) and the first 15 nucleotides of exon 1 (a blunted BanI fragment excised from the Gig1 cDNA clone) into the blunted XbaI site of pPDnLacZ3pA. To generate PL452-EF, Gig1 intron 1 sequences from nucleotides 170 to 550, were amplified by PCR with the following primers; 5 0 -TATGCTAGCCTGTCGGTGCTCAGAGG-3 0 (for) and 5 0 -TATG TCGACTAAGTGCTTAGGA TGTCCAG-3 0 (rev), digested with NheI and HincII, blunted with Klenow, and inserted into the blunted BamHI site of PL452 (Liu et al., 2003) . The 5 0 Gig1nLacZ3pA fragment from pPD5 0 Gig1nLacZ3pA was excised by digestion with SalI, and introduced into the SalI site of PL452-EF to generate the Gig1 mini-targeting vector containing an nLacZ3pA-floxed PGKNeo cassette flanked by Gig1 fragments that are homologous to the targeting site. Subcloning Gig1 genomic DNA and insertion of the nLacZ3pA-floxed PGKNeo cassette into the retrieved Gig1 genomic DNA were performed by a recombineering-based method (Liu et al., 2003) . Two PCR products which correspond to the ends of 5 0 and 3 0 homology arms were amplified with the following primer sets; 5 0 arm: 5 0 -ATAAGCGGCCGCAGGTTACATGTCATCTGT GAG -3 0 (for) 5 0 -GTCAAGCTTCTTGCTCAGATTGCACAGGTC -3 0 (rev); 3 0 arm: 5 0 -GTCAAGCTTGAGATATC CTGACACTGTATC -3 0 (for) 5 0 -TCTACTAGTGATATCTGCTCACTGATAATC -3 0 (rev), and digested with NotI/HindIII and HindIII/SpeI, respectively. A gap repair plasmid (PL253-ABYZ) was generated by inserting those digested PCR products together into the NotI/SpeI of PL253. To generate PL253-AtoZ plasmid, subcloning of 8.2 kb Gig1 genomic DNA was performed via gap repair with HindIII digested PL253-ABYZ, RP24-229P11 BAC DNA (Children Hospital Oakland Research Institute) and EL350 host bacteria as described previously (Liu et al., 2003) . The final Gig1 targeting vector was generated by recombineering using the NotI fragment of the Gig1 mini-targeting vector, PL253-AtoH and EL350 host bacteria as described previously (Liu et al., 2003) .
Production of transgenic and gene-targeted mice
MyoDGFP (À24GFP) transgenic mice were produced by the University of Pennsylvania Transgenic and Chimeric Mouse Facility by pronuclear injection of BL6SJLF2/J single-cell embryos. Stable lines were produced by crossing to FVB mice and homozygous lines established by interbreeding. Two lines were characterized, each of which faithfully recapitulated MyoD expression in skeletal muscle between E10.5 and E14.5, the developmental stages used in the present study (see Fig. 6A ; data not shown). The pattern of GFP expression closely matched that of lacZ in À24lacZ embryos (Chen et al., 2001) , which utilized identical regulatory elements.
ES cell electroporation and production of chimeras was performed by the University of Connecticut Gene Targeting and Transgenic Facility (GTTF). The Gig1nLacZ3pA targeting vector was linearized with NotI and electroporated into 129S6/C57BL6 hybrid ES cells (D1: established by GTTF). Screening of ES cell clones was performed by Southern blot hybridization with the PCR-generated probes corresponding to sequences outside of the 5 0 and 3 0 homology arms. The following primers were used:
Chimeric mice were produced from targeted ES cell clones by aggregation with CD1 embryos. Chimeric mice were crossed to Hprt
Cre/+ mice (Jackson Labs; Tang et al., 2002) to remove the floxed PGKNeo cassette, removal of which was confirmed by PCR using the following primers: 5 0 -CCTGCAGCCCAATTCCGATCATATTC-3 0 (for); 5 0 -GACCTCGT CCAGCTCCCAAGTTCC-3 0 (rev). Germ-line transmission of the targeted allele was assessed by PCR for lacZ with a forward primer that lies within the nlacZ cassette (5 0 -CCGAAATCCCGAATCTCTATC-3 0 ) and a reverse primer in intron 1 of Gig1 (5 0 -TTGGCTTCATCCACCACATAC-3 0 ). Lines were maintained by breeding to FVB mice. Embryos from at least two litters were analyzed for each developmental time point. For staging, noon on the day of the vaginal plug was considered E0.5. Embryo staging was confirmed by somite counts.
RT-PCR
Total RNA was extracted from appropriately staged mouse embryos using the RNeasy mini kit (Qiagen), and treated with RQ1 DNase I (Promega). cDNA was generated using the ProtoScript First Strand cDNA Synthesis Kit according to the manufacturer's protocol (NEB). Gig1 transcripts were detected using exon 2 primers, 5 0 -TTAAGCGGGAGATGA CCTTC-3 0 (for) and 5 0 -CTTTCCGCTTCTGCTCAAGA-3 (rev), generating a 230 bp product, and primers anchored in exon 7 (5 0 -AGTCACTTTC ACTGGCGTTC-3 0 ) and 9 (5 0 -CAGGCGGTGCACCAC ATGTC-3 0 ), generating a 195 bp product. The b-actin PCR (280 bp) was performed with primers 5 0 -TAGGCACCAGGGTGTGATGG-3 0 (for) and 5 0 -GTAC ATGGCTGGGGTGTTGAA-3 0 (rev).
Whole-mount in situ hybridization
Whole mount in situ hybridization was performed as described previously (Henrique et al., 1995) with the following modifications. Hybridization was performed in 50% formamide/5· SSC pH 4.5/2% SDS/2% Boehringer's Blocking Reagent/250 lg/ml yeast tRNA/ 100 lg/ml heparin overnight at 70°C. The hybridized embryos were incubated in Solution X (50% formamide/2· SSC pH 4.5/1% SDS) for 20 min at 70°C four times and in a 1:1 mixture of Solution X and MABT (100 mM maleic acid/150 mM NaCl/0.1% Tween-20, pH 7.5) for 20 min at 70°C. For detection of Scleraxis mRNA after Xgal staining, rehydrated embryos were incubated in 1% NP-40/1% SDS/0.5% deoxycholate/50 mM Tris-HCl pH 8.0/1 mM EDTA/ 150 mM NaCl two times for 20 min each, rinsed in PTW (PBS/0.1% Tween-20), incubated in 10 lg/ml Proteinase K/PTW for 20 min, and post-fixed in 4% paraformaldehyde (PFA)/0.2% glutaraldehyde/PTW for 20 min.
Digoxigenin-labeled riboprobes were synthesized according to the manufacturer's protocol (Roche). The MyoD probe corresponded to nucleotides 782-1747 of its cDNA (NM_010866). The Gig1 probe corresponded to nucleotides 2088-3065 of 3 0 UTR sequences (AF292939). The Scleraxis template represented its entire coding sequence.
Histology and X-gal histochemistry
For detection of both GFP and b-gal in whole-mounts, embryos were fixed with 2% PFA/0.25% glutaraldehyde in PBS (pH 7.4) for 30-60 min at 4°C, and rinsed in three changes of PBS over 30 min. Following incubated in X-gal staining solution (2 mM MgCl 2 , 4 mM K 3 Fe(CN) 6 , 4 mM K 4 Fe(CN) 6 , 0.1% Triton X-100, and 0.1% X-gal) in PBS at 37°C overnight, embryos were rinsed in PBS.
For sequential detection of lacZ and Scleraxis mRNAs, embryos fixed in 1% PFA/PBS for 1 h at 4°C were processed for X-gal staining for 2-4 h at 37°C, rinsed in PBS, post-fixed in 4% PFA/PBS overnight at 4°C, and then processed for in situ hybridization for Scleraxis as above.
For detection of GFP and b-gal in cryosections, embryos were fixed in 2% PFA/0.25% glutaraldehyde/PBS for 30 min or 1% PFA/PBS for 1 h, rinsed with PBS and cryoprotected in 30% sucrose for 2 h at 4°C. After embryos were embedded in O.C.T. (Tissue-Tek) and frozen in liquid nitrogen, 10 lm cryosections were collected using a Tape-Transfer System (CryoJane; Instrumedics), rinsed in PBS and incubated in 0.1 lg/ml 4 0 6 0 -diamidino-2-phenylindole dihydrochloride (DAPI)/PBS. Sections were photographed in 10% glycerol/PBS using epifluorescence, stained with X-gal as above, and re-photographed.
Standard methods were used for paraffin histology of X-gal-stained embryos.
Photography and images
Images were captured using a Hamamatsu C5810 color video camera and a Leica MZFLIII stereomicroscope (whole mounts) or Nikon E600 microscope (sections) with either bright-field or epifluorescence illumination. For co-detection of GFP and b-gal, GFP images were captured prior to X-gal staining to avoid quenching of the GFP fluorescence by the X-gal deposits. After re-photographing, GFP and X-gal images were aligned and merged using Adobe Photoshop. In some cases, the GFP signal was artificially colorized for improved visualization of co-localized GFP and b-gal signals.
